What is a light chain myelom?
Multiple myeloma is a form of cancer that affects human bone marrow and blood cells. There are different phases and varieties of this incurable form of cancer and each causes different symptoms and levels of risk for well -being and life of patients. A light chain myeloma, also known as a light chain disease, is a type of multiple myeloma in which malignant bone marrow cells produce free monoclonal proteins of the light chain. This type of myeloma is usually more serious than a classic species. One of the narrated symptoms of this form of cancer is that cancer bone marrow cells produce monoclonal proteins of a light chain. However, cancer cells do not produce heavy chain proteins or complete immunoglobulin. They produce a light chain protein that can be easily filtered with the kidney. These proteins are called Bence-Jones proteins.Agresive than a typical form. Patients face faster double time for this disease and tend to develop bone lesions or osteolyticsions. They also havetend to have increased prevalence of hypercalcaemia or calcium in the blood. Their risk of amyloidosis and leukemia is also higher because they progress further to the later stages of the disease. Light chain myeloma also has a higher level of kidney failure than in common patients with myeloma, and in fact it usually causes their death.
When a patient goes to a doctor with symptoms of multiple myeloma, the doctor first looks at the main indicators of multiple myeloma to determine what type and stage of cancer they have. The main indicators of myeloma of the light chain are elevated blood calcium levels, low levels of red blood cells, bone lesions and bone pain and reduced kidneyfunction. Patients who have no clear evidence of these symptoms may have what is called a smoldering multiple myeloma.
After diagnosis, the doctor may determine the course of treatment. Treatment will depend on a specific type of cancer and the stage of ONthe emotion the patient has. Treatment may include chemotherapy. Experimental drugs can also be used. The patient may be administered by bone marrow transplantation. Doctors may prescribe medicines that help protect patients from side effects of multiple myeloma, including kidney damage, bone decay and infection.